Viewing Company BLVD Centers Corp | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

BLVD Centers Corp Stock Symbol: CXV-X

Notes:

Formerly Convalo Health International Corp (June 2017)

Last Price Recorded: $0.1050 on 2017-10-20

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-10-12 WATCH Bruce Campbell (2)

It has been a bit of a disappointment in the how they have executed.  They are in the rehabilitation business, acquiring centers.  They were driving everything out of the head office and each center was not that profitable.  Now each manager is incentivized with how profitable they are.  We have to see how this works.  He has it on his radar screen.


Price:
$0.105
Subject:
CANADIAN
Bias:
OPTIMISTIC
Owned:
No
2017-07-26 COMMENT Bruce Campbell (2)

This has been disappointing. They’ve changed their compensation program for managers, where they used to operate everything out of head office with no individual profit centres for their individual locations. Now, the individual manager is responsible for their profit and loss. He is hoping to see an uptick in profitability when this starts to come through, probably another quarter or two. Long-term this should be a very strong business, because they deal with addiction treatment in a number of different forms.


Price:
$0.125
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
No
2017-04-26 COMMENT Bruce Campbell (2)

They are changing the way they compensate each of the ground managers. Have built out 5 pods so far, which offered in-patient services as well as day services. They were making all the decisions from a top down perspective, and the individual centres were not as profitable as they should have been. They recently adjusted the compensation structure, so now the managers are compensated on the profitability of each of their individual pods. This next quarter will not be indicative of that change, it will be one quarter after that. It has a lot of potential, but they haven’t lived up to that yet.


Price:
$0.120
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Unknown
2017-01-25 PAST TOP PICK Bruce Campbell (2)

(A Top Pick Dec 9/15. Down 59.32%.) In the rehab treatment business in the US, and it has been a huge disappointment. They continue to execute. Valuation was ahead of what he should have paid for it. Also, it has taken a little longer for them to roll out what they were trying to accomplish. He got stopped out.


Price:
$0.115
Subject:
CANADIAN
Bias:
BULLISH
Owned:
No
2016-10-26 HOLD Bruce Campbell (2)

(Market Call Minute.) If he owned this, he would probably wait to see how their quarter continues to improve.


Price:
$0.110
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
No
2016-09-09 PAST TOP PICK Fabrice Taylor

(A Top Pick Aug 12/15. Down 133%.) This got caught up in the healthcare meltdown, but there are also some company specific problems. Revenues are okay, but they are not profitable. Thinks they need to bring in management that actually knows the industry better. He would watch for 2 more quarters, and if they don’t show improvement in the bottom line, he would consider exiting.


Price:
$0.120
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Yes
2016-06-30 BUY Bruce Campbell (2)

They continue to execute fairly well.  They have 5 of these pods and are guiding for $80 million of run rate by the end of the year.  They have to get up to speed for you to see this level.  They have started up a lab for all the samples they take from patients.  They are bringing this in-house and it will be a big savings for them from an expense point of view.  They are fairly valued, but if you look at the run rate by year end then they look good.


Price:
$0.205
Subject:
CANADIAN
Bias:
OPTIMISTIC
Owned:
Yes
2016-06-24 DON'T BUY Ryan Modesto

Doesn’t follow this too closely. A rollup for rehab facilities. He doesn’t buy into the rehab market rollup story. There are better quality companies out there.


Price:
$0.230
Subject:
CANADIAN SMALL & MIDCAPS
Bias:
UNKNOWN
Owned:
Unknown
2016-05-17 PAST TOP PICK Bruce Campbell (2)

(A Top Pick May 20/15. Down 54.76%.) A high flyer about a year ago, and probably got ahead of itself. However, they are doing all the right things. He was very close to making this a Top Pick because they continue to execute really well. They’ve opened 4 new clinics in the last 45 days, and have also opened their lab. They are hoping to have a run rate of about 80 million by the end of this year. He still really likes this.


Price:
$0.285
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Yes
2016-04-27 SPECULATIVE BUY Fabrice Taylor

He likes this. This is in the drug rehab space in the US. Since the government has mandated funding for these for insurance companies, there is a lot of tailwind for it. The stock has been volatile and controversial at times but the numbers, if they come in halfway right, should move the stock. High risk story, but lots of cash on the balance sheet.


Price:
$0.305
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Yes
2016-04-13 TOP PICK Bruce Campbell (2)

(A Top Pick April 8/15. Down 57.94%.) Continuing to do everything right and have really good growth. Small caps haven’t been in favour in this market. The “abuse” treatment business is about a $35 billion business in the US, and there is no one competitor that has more than $200 million, so there is huge opportunity for them to capitalize on. Have 4 pods open now, and will have 5 more by the end of this year. Thinks the run rate revenue by the end of this year could be around $100 million.


Price:
$0.265
Subject:
CANADIAN
Bias:
CAUTIOUSLY OPTIMISTIC
Owned:
Yes
2016-03-09 COMMENT Fabrice Taylor

Has been buying a lot of this. They have $0.10 a share in cash and $30 million in revenue. Doing 30% operating profits right now. To him, the business is doing very well. The problem is the stock price. There was some controversy with management, but he saw that the 2 founders had bought 1.5 million shares last week. If you do what they do, you will probably do okay. The new CEO is going to start marketing the story, so it should find a new audience and start to bounce back.


Price:
$0.235
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Yes
2016-03-03 DON'T BUY Ryan Modesto

Rolling up rehab facilities. There is probably growth potential here, but not a company he would buy into. Doesn’t see a huge need to consolidate the rehab facility industry. There was a recent news release about an acquisition called Hollywood Rehab where there was misrepresentation in the purchase, but in the same news release the founders also decided to step down and hand over responsibility to the operation managers. Markets knew this would happen eventually.


Price:
$0.225
Subject:
CANADIAN SMALL & MIDCAPS
Bias:
UNKNOWN
Owned:
No
2016-02-24 COMMENT Bruce Campbell (2)

This is a story about rehabilitation of people who have substance abuse in the US. Originally they were looking at this as an acquisition story, but have changed that and are now doing it organically, and have been growing phenomenally well. As this broke down and hit some technical levels, he trimmed back his position. Recently has been looking to pick up more of this.


Price:
$0.225
Subject:
CANADIAN
Bias:
CAUTIOUS
Owned:
Yes
2016-01-13 COMMENT Bruce Campbell (2)

Has a small piece of this in his growth fund. This is really a cash flow business. They are in substance rehabilitation. Bought their initial business in LA and are now growing out and making acquisitions, but have also been building and seeing phenomenal growth. Have 2 pods in LA and are going to be adding one in San Francisco. Really high margins. Revenues are all in US$.


Price:
$0.285
Subject:
CANADIAN
Bias:
CAUTIOUS
Owned:
Yes
Showing 1 to 15 of 35 entries
<< < 1 2 3 > >>

No Comments.


You must be logged in to comment.